Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pharmacokinetics Services market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pharmacokinetics Services market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Segmented by End User/Segment
Small & Medium Enterprise
Large Enterprise
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Shanghai Medicilon Inc. (China)
SGS SA (Switzerland)
Pharmaceutical Product Development, LLC (US)
PAREXEL International Corporation (US)
Pacific BioLabs (US)
LGC Limited (UK)
GVK Biosciences Private Limited (India)
Frontage Labs (US)
Evotec AG (Germany)
Eurofins Scientific, Inc. (Luxembourg)
Creative Bioarray (US)
Charles River Laboratories International, Inc. (US)
Certara, L.P. (Germany)
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Pharmacokinetics Services Market Status and Forecast (2016-2027) 1.3.2 Global Pharmacokinetics Services Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Pharmacokinetics Services Supply by Company 2.1 Global Pharmacokinetics Services Sales Value by Company 2.2 Pharmacokinetics Services Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Pharmacokinetics Services Market Status by Category 3.1 Pharmacokinetics Services Category Introduction 3.1.1 Small Molecules Pharmacokinetics Services 3.1.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services 3.2 Global Pharmacokinetics Services Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Pharmacokinetics Services Market Status by End User/Segment 4.1 Pharmacokinetics Services Segment by End User/Segment 4.1.1 Small & Medium Enterprise 4.1.2 Large Enterprise 4.2 Global Pharmacokinetics Services Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Pharmacokinetics Services Market Status by Region 5.1 Global Pharmacokinetics Services Market by Region 5.2 North America Pharmacokinetics Services Market Status 5.3 Europe Pharmacokinetics Services Market Status 5.4 Asia Pacific Pharmacokinetics Services Market Status 5.5 Central & South America Pharmacokinetics Services Market Status 5.6 Middle East & Africa Pharmacokinetics Services Market Status6 North America Pharmacokinetics Services Market Status 6.1 North America Pharmacokinetics Services Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Pharmacokinetics Services Market Status 7.1 Europe Pharmacokinetics Services Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Pharmacokinetics Services Market Status 8.1 Asia Pacific Pharmacokinetics Services Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Pharmacokinetics Services Market Status 9.1 Central & South America Pharmacokinetics Services Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Pharmacokinetics Services Market Status 10.1 Middle East & Africa Pharmacokinetics Services Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Pharmacokinetics Services Market Forecast by Category and by End User/Segment 12.1 Global Pharmacokinetics Services Sales Value Forecast (2022-2027) 12.2 Global Pharmacokinetics Services Forecast by Category 12.3 Global Pharmacokinetics Services Forecast by End User/Segment13 Global Pharmacokinetics Services Market Forecast by Region/Country 13.1 Global Pharmacokinetics Services Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Shanghai Medicilon Inc. (China) 14.1.1 Company Information 14.1.2 Pharmacokinetics Services Product Introduction 14.1.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 SGS SA (Switzerland) 14.2.1 Company Information 14.2.2 Pharmacokinetics Services Product Introduction 14.2.3 SGS SA (Switzerland) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Pharmaceutical Product Development, LLC (US) 14.3.1 Company Information 14.3.2 Pharmacokinetics Services Product Introduction 14.3.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 PAREXEL International Corporation (US) 14.4.1 Company Information 14.4.2 Pharmacokinetics Services Product Introduction 14.4.3 PAREXEL International Corporation (US) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Pacific BioLabs (US) 14.5.1 Company Information 14.5.2 Pharmacokinetics Services Product Introduction 14.5.3 Pacific BioLabs (US) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 LGC Limited (UK) 14.6.1 Company Information 14.6.2 Pharmacokinetics Services Product Introduction 14.6.3 LGC Limited (UK) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 GVK Biosciences Private Limited (India) 14.7.1 Company Information 14.7.2 Pharmacokinetics Services Product Introduction 14.7.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Frontage Labs (US) 14.8.1 Company Information 14.8.2 Pharmacokinetics Services Product Introduction 14.8.3 Frontage Labs (US) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Evotec AG (Germany) 14.9.1 Company Information 14.9.2 Pharmacokinetics Services Product Introduction 14.9.3 Evotec AG (Germany) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Eurofins Scientific, Inc. (Luxembourg) 14.10.1 Company Information 14.10.2 Pharmacokinetics Services Product Introduction 14.10.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 Creative Bioarray (US) 14.12 Charles River Laboratories International, Inc. (US) 14.13 Certara, L.P. (Germany)15 Conclusion16 Methodology